Poly Medicure Limited Share Price and Company Fundamentals
Last traded: Yesterday at 10:00 AM
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, such as blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, foley balloon and urine drainage catheters, and urine collection bags with measured volume meters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.
Key Metrics
PE ratio
39.72
PB ratio
4.71
Dividend yield
0.26%
Beta
-0.17
Market cap
₹137.62B
Enterprise value
₹128.98B
Company profile
| Industry / Sector | Medical Instruments & Supplies / Healthcare |
|---|---|
| Full time employees | 3082 |
| Website | https://www.polymedicure.com |
| Mailing address | 232B Okhla Industrial Estate 3rd Floor Phase III New Delhi 110020 India |
| Phone / Fax | 91 11 2632 1838 / 91 11 2632 1839 |
Dividends
Dividend yield
0.26%
Dividend amount
₹3.50
Payout ratio
10.25%
5Y Avg. yield
-%
Poly Medicure Limited paid ₹3.50 dividend and the ex-dividend date was 18 Sep 2025.The dividend payout ratio is 10.25%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.POLYMED dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Poly Medicure Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Himanshu Baid | CEO, MD & Director | 57 | |
| Mr. Jugal Kishore Baid | Founder & Non Executive Director | 83 | |
| Mr. Naresh Vijayvergiya | Chief Financial Officer | 58 | |
| Mr. Avinash Chandra | Company Secretary & Compliance Officer | ||
| Mr. Rishi Baid B.S.M.E | Joint MD & Executive Director | 53 | |
| Mr. Vishal Baid C.A. | Executive Director & Senior VP of Corporate Sales & Marketing | 51 | |
| Mr. P. K. Rastogi C.A. | Assistant Vice President of Finance & Accounts | 54 | |
| Mr. Rahul Gautam | President of Strategy & Corporate Development | ||
| Mr. Lokender Kumar | Senior General Manager & HR | ||
| Mr. Pankaj Kumar Gupta B.E. | President of R&D & Additional Executive Director | 58 |
Profitability and management effectiveness
Profit margin
19.51%
Operating margin
16.70%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Poly Medicure Limited is 137.62B and its enterprise value is 128.98B. The enterprise value to revenue ratio of POLYMED is 7.24. The enterprise value to EBITDA ratio of POLYMED is 28.71.
Poly Medicure Limited (NSE:POLYMED) Frequently Asked Questions
1. What is Poly Medicure Limited's Stock Symbol?
Poly Medicure Limited trades on NSE under the ticker symbol "POLYMED".
2. What is Poly Medicure Limited's stock price today?
One share of POLYMED stock can currently be purchased for approximately ₹1356.1.
3. How can I contact Poly Medicure Limited?
Poly Medicure Limited's mailing address is 232B Okhla Industrial Estate 3rd Floor Phase III New Delhi 110020 India. The company can be reached via phone at 91 11 2632 1838.
4. What is Poly Medicure Limited's official website?
The official website of Poly Medicure Limited is https://www.polymedicure.com.